Fuda Cancer Hospital
Stomach cancer treatment cost in China runs from $100 to $600 for a gastroscopy. Major procedures like stomach cancer surgery costs $18,500 to $34,500, while chemotherapy for stomach cancer ranges from Price on request to Price on request . Total expenses depend on the cancer stage, hospital tier, and surgical approach. International patients typically see 80-85% savings compared to the US. Top cities for oncology include Guangzhou, Shanghai, and Beijing.
Typical Stomach Cancer Treatment Costs in China
Bookimed Expert Insight: Advanced-stage patients often benefit from integrated, non-traditional protocols. Fuda Cancer Hospital specializes in late-stage care using NanoKnife and cryosurgery. This JCI-accredited facility has served 30,000 international patients. For those needing precision radiation, Dr. Liu Shi Xin at Xiamen Humanity Hospital offers expert-led radiotherapy. Choosing specialized oncology hubs provides better value for complex, multidisciplinary cases than general hospitals.
| China | Turkey | Austria | |
| Stomach resection | from $18,500 | from $18,450 | from $22,000 |
| Stomach cancer surgery | from $18,500 | from $8,500 | from $30,000 |
| Radiation therapy for stomach cancer | from $8,500 | from $3,250 | from $6,896 |
| Proton-beam therapy | from $36,500 | from $1,500 | from $80,000 |
| NanoKnife | from $21,600 | from $9,500 | from $25,000 |
Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.
Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.
Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.
Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.
He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).
Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.
He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.
Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).
He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.
Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.
Chinese oncologists at top-tier facilities follow national certification standards that align with international benchmarks. Leading surgeons often hold Chief Physician titles and practice in JCI-accredited hospitals. These specialists frequently maintain memberships in global bodies like the Chinese Anti-Cancer Association while following internationally recognized CSCO treatment guidelines.
Bookimed Expert Insight: Case volume in China often translates to higher technical proficiency for stomach cancer. Specialists at flagship hospitals may perform 1,000+ gastrectomies annually. This volume far exceeds most Western counterparts. When selecting a surgeon, prioritize those at JCI-accredited facilities in Guangzhou or Shanghai. These doctors frequently hold dual training from Western or Japanese institutions, ensuring they meet rigorous international surgical protocols.
Patient Consensus: Patients emphasize choosing surgeons at Tier-1 hospitals in major cities for the best results. They note that top doctors often speak English well and have extensive experience with robotic or laparoscopic techniques.
The 5-year survival rate for stomach cancer in China ranges from 35.1% to 46.1% nationwide. Specialized cancer centers report surgical survival rates reaching 69.8%. Early-stage diagnosis (Stage I) offers the best prognosis. Survival for these patients often reaches 85% to 95%.
Bookimed Expert Insight: Clinical data shows a major distinction between general hospitals and high-volume specialty centers in Guangzhou. Fuda Cancer Hospital has treated over 30,000 international patients. It focuses on minimally invasive therapies like NanoKnife. Choosing centers that prioritize these technologies over standard chemotherapy often improves quality of life during treatment.
Patient Consensus: Patients emphasize that frequent screening in China helps catch cancer earlier than in Western countries. Many survivors stress the importance of verifying that a surgeon performs at least 20 gastrectomies annually for the best outcomes.
Laparoscopic and robotic gastrectomy are widely available in China for treating stomach cancer. These minimally invasive techniques are safe alternatives to open surgery. Both approaches offer faster recovery times. Surgeons use the Da Vinci Robotic System for high precision and 3D visualization.
Bookimed Expert Insight: While robotic surgery takes longer to set up, it is the superior choice for patients with complex cases or high BMI. Fuda Cancer Hospital in Guangzhou treats over 30,000 international patients and maintains JCI-accredited safety standards. Their specialists, like Dr. Leng Yin, often prioritize these minimally invasive methods to reduce trauma in advanced cases.
Patient Consensus: Patients find that the smaller incisions lead to much less pain after surgery. They often feel more comfortable and mobile just a few days after the procedure.
Stomach cancer treatment in China typically requires between 4 weeks and 6 months depending on the stage. Early-stage endoscopic procedures take only 1 to 2 days. Complex surgical pathways usually involve 2 weeks of hospitalization followed by 4 weeks of local recovery before flying.
Bookimed Expert Insight: Patients should note that Chinese clinical protocols, like those at Fuda Cancer Hospital, often favor longer inpatient stays than Western facilities. While a gastrectomy might have a 5-day hospital stay in the US, Chinese specialists often require 14 to 21 days. This approach focuses on intensive monitoring for post-operative leaks and immediate nutritional stabilization before discharge to a hotel.
Patient Consensus: Patients emphasize building in a 2-week buffer for discharge delays or minor recovery hurdles like delayed gastric emptying. Many recommend arranging follow-up chemotherapy with a local oncologist at home to avoid staying in-country for several months.
Guangzhou, Beijing, and Shanghai are the primary Chinese hubs for international patients seeking experienced stomach cancer care. These cities host JCI-accredited facilities specializing in advanced therapies. Specialized centers utilize cryosurgery, NanoKnife, and robotic-assisted resections for complex and late-stage gastric oncology cases.
Bookimed Expert Insight: While Beijing and Shanghai are prestigious, Guangzhou offers a unique balance of high volume and lower costs. Our data indicates that Sun Yat-sen University Cancer Center provides treatments approximately 30% to 50% more affordably than Beijing facilities. Furthermore, clinics like Fuda Cancer Hospital offer specialized interventions such as cryosurgery for late-stage cases. These are often unavailable at standard international hubs.
Patient Consensus: Patients note that public hospitals with dedicated international departments provide the best surgical volume. Many recommend hiring private translators in Shanghai and Beijing to navigate the complex hospital systems efficiently.
Post-operative dietary support for stomach cancer in China follows structured Enhanced Recovery After Surgery (ERAS) protocols. International patients receive personalized plans. These plans transition from full liquids to regular meals over 6 months. Multidisciplinary teams, including clinical dietitians, monitor nutritional intake and hydration status to ensure safe recovery.
Bookimed Expert Insight: JCI-accredited clinics like Fuda Cancer Hospital demonstrate a commitment to international safety standards. With over 30,000 international patients treated, these centers adapt traditional Chinese recovery foods. For example, dietitians may remove MSG from menus to better suit Western tastes. They also provide printed English guides to manage recovery after discharge.
Patient Consensus: Patients note that rice porridge and protein shakes are recovery staples. Many recommend using translation apps for dietitian visits and bringing electrolyte packets for easier hydration during the liquid phase.
Most international patients require a medical visa for stomach cancer treatment in China. JCI-accredited facilities provide essential invitation letters required for S1, S2, or M visas. Citizens from over 50 countries may currently benefit from 30-day visa-free entry for medical purposes.
Bookimed Expert Insight: Fuda Cancer Hospital serves over 30,000 international patients and manages complex visa paperwork efficiently. Our data shows hospitals in Guangzhou often email invitation letters within 48 hours. This speed is vital for patients seeking time-sensitive therapies like NanoKnife or Cryosurgery. Choosing a hospital experienced in international logistics ensures your entry permit matches the required treatment duration.
Patient Consensus: Patients note that emailing a preliminary diagnosis and passport scan quickly secures the invitation letter. Many suggest traveling with a companion as hospitals often bundle family visa invitations together.